GPAT4 and obesity due to melanocortin 4 receptor deficiency: Based on the lessons learned from the agpat6-deficient mice, we hypothesized that variation in the human AGPAT6 may associate with obesity, hypertriglyceridemia, insulin resistance and type 2 diabetes susceptibility.